Detalhe da pesquisa
1.
Berdazimer gel for molluscum contagiosum: An integrated analysis of 3 randomized controlled trials.
J Am Acad Dermatol
; 90(2): 299-308, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804936
2.
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation.
J Am Acad Dermatol
; 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331098
3.
Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis.
Pediatr Dermatol
; 41(3): 438-444, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413239
4.
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021.
J Eur Acad Dermatol Venereol
; 37 Suppl 1: 14-19, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546465
5.
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
JAMA
; 328(11): 1073-1084, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125472
6.
Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program.
Dermatol Surg
; 47(4): 511-515, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587381
7.
DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study.
Dermatol Surg
; 47(1): 48-54, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32773446
8.
Tazarotene 0.045% Lotion for Moderate-to-Severe Acne Patients: Pooled Phase 3 Analysis by Age and Sex.
J Drugs Dermatol
; 20(6): 608-615, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34076400
9.
A Phase 3, Randomized Trial Demonstrating the Improved Efficacy and Patient Acceptability of Fixed Dose Calcipotriene and Betamethasone Dipropionate Cream.
J Drugs Dermatol
; 20(4): 420-425, 2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852251
10.
Improvements in Submental Contour up to 3 Years After ATX-101: Efficacy and Safety Follow-Up of the Phase 3 REFINE Trials.
Aesthet Surg J
; 41(11): NP1532-NP1539, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617632
11.
Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients With Psoriasis
J Drugs Dermatol
; 18(8): 776-788, 2019 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31424708
12.
Efficacy of a Once-Daily Fixed Combination Halobetasol (0.01%) and Tazarotene (0.045%) Lotion in the Treatment of Localized Moderate-to-Severe Plaque Psoriasis
J Drugs Dermatol
; 18(3): 297-299, 2019 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30909352
13.
Efficacy of Topical Botanical Treatment of Children With Mild to Moderate Atopic Dermatitis
J Drugs Dermatol
; 18(10): 1038-1045, 2019 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31584783
14.
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris
J Drugs Dermatol
; 18(6): 542, 2019 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31251546
15.
Validation of Botanical Treatment Efficiency for Adults and Children Suffering from Mild to Moderate Atopic Dermatitis
J Drugs Dermatol
; 18(6): 557, 2019 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31251548
16.
Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy.
J Drugs Dermatol
; 17(7): 723-726, 2018 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30005093
17.
Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials.
J Drugs Dermatol
; 17(10): 1062-1069, 2018 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30365586
18.
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
J Drugs Dermatol
; 17(9): 987-996, 2018 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30235387
19.
Commentary on the Influence of Topical Anesthesia on Superficial Sensitivity: A Double Blind, Randomized, Placebo Controlled Study on 48 Healthy Subjects.
Dermatol Surg
; 46(12): 1599, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33252461
20.
Who do you prefer? A study of public preferences for health care provider type in performing cutaneous surgery and cosmetic procedures in the United States.
Dermatol Surg
; 40(6): 671-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24852472